Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
Clinical trial NCT04935476 · UNKNOWN
Trial details
- NCT number
- NCT04935476
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-22
- Primary completion
- 2022-03-31
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.